-
U.S. and EU Kidney Groups Align for Global Innovation Consortium
prnasia
March 12, 2021
The American Association of Kidney Patients (AAKP), the largest U.S. kidney patient organization, joined the European Kidney Patients' Federation (EKPF) and the European Kidney Health Alliance (EKHA) in a new collaboration designed to expand the role ...
-
Urine test developed to diagnose subclinical kidney transplant rejection
europeanpharmaceuticalreview
March 09, 2021
The novel, non-invasive test detects a rejection signature within mRNA isolated from urine and could, with further development, be used instead of biopsies to identify transplant rejection.
-
Kidney Research UK pledges support to Accelerate@Babraham initiative
pharmatimes
February 19, 2021
Charity Kidney Research UK (KRUK) has been confirmed as a strategic partner to the Accelerate@Babraham initiative at the Babraham Research Campus.
-
Voclosporin approved by FDA to treat lupus nephritis
europeanpharmaceuticalreview
January 26, 2021
The FDA has approved Aurinia Pharmaceuticals’ LupkynisTM(voclosporin) for the treatment of lupus nephritis, alongside standard-of-care.
-
First Patient Dosed in Trial to Treat Complications in COVID-19
americanpharmaceuticalreview
October 22, 2020
Arch Biopartners has dosed the first patient in the Phase II trial of its lead drug LSALT peptide, targeting prevention of acute lung injury, acute kidney injury and other complications caused by inflammation in hospitalized patients with moderate to ...
-
KidneyIntelX to Predict Major Adverse Kidney Events in COVID-19 Patients
americanpharmaceuticalreview
April 21, 2020
Renalytix announced the KidneyIntelX™ platform will be used by investigators from the Icahn School of Medicine at Mount Sinai to assess the risk of adverse kidney events in patients diagnosed with COVID-19.
-
How a Seattle Genetics cancer drug could help lupus patients
fiercebiotech
April 13, 2020
The kidney is often a target of autoimmune diseases, including lupus. But little is known about how immune cells adapt to the low oxygen level in renal tissue to wreak havoc.
-
Xortx Therapeutics to assess XRx-101 for Covid-19 treatment
.pharmaceutical-technology
March 18, 2020
Xortx Therapeutics is set to explore XRx-101, a formulation of Oxypurinol, as a potential treatment for acute kidney and lung injury associated with Covid-19.
-
Are Doctors Discarding 'Injured' Kidneys That Might Be Used for Transplant?
drugs
January 17, 2020
Many of the donor kidneys that are discarded each year in the United States could instead be effectively transplanted, a large new study suggests.
-
Big Advances Made Against Diabetes in 2019
drugs
January 02, 2020
A new artificial pancreas system, drugs that help control blood sugar and protect the heart and the kidneys, a new medication that delays type 1 diabetes ...